The impact of using the combined oral contraceptive pill for cycle scheduling on gene expression related to endometrial receptivity

Human Reproduction

Volumn 29, Issue 6, 2014, Pages 1271-1278

  Bermejo, Alfonso ^a   Iglesias, Carlos ^a   Ruiz Alonso, María ^b   Blesa, David ^c   Simón, Carlos ^c   Pellicer, Antonio ^c   García Velasco, Juan ^a  

^a INSTITUTO VALENCIANO DE INFERTILIDAD   (Spain)

^b Iviomics SL   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Contraceptive pill; Cycle programming; Endometrial receptivity; Gene expression; GnRH antagonist

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; ETHINYLESTRADIOL PLUS LEVONORGESTREL; GONADORELIN ANTAGONIST; LUTEINIZING HORMONE; PROGESTERONE; RECOMBINANT FOLLITROPIN; TYROSINE 3 MONOOXYGENASE; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CELL COMMUNICATION; CONTROLLED STUDY; ENDOMETRIAL RECEPTIVITY; ENDOMETRIUM; ENDOMETRIUM BIOPSY; ESTRADIOL BLOOD LEVEL; EXTRACELLULAR MATRIX; FEMALE; FEMALE GENITAL SYSTEM FUNCTION; FERTILIZATION IN VITRO; GENE EXPRESSION; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; LUTEINIZING HORMONE BLOOD LEVEL; MENSTRUAL CYCLE; MICROARRAY ANALYSIS; NORMAL HUMAN; OOCYTE MATURATION; OOCYTE RETRIEVAL; PROGESTERONE BLOOD LEVEL; CONTROLLED OVARIAN STIMULATION; FEMALE GENITAL TRACT PARAMETERS; HUMAN TISSUE; INFERTILITY THERAPY; MENSTRUAL CYCLE SCHEDULING; MENSTRUATION; OOCYTE; RANDOMIZED CONTROLLED TRIAL; TISSUE MICROARRAY; YOUNG ADULT; ADOLESCENT; DRUG EFFECTS; GENETICS; METABOLISM; NIDATION; OVULATION INDUCTION; PROCEDURES;

ADOLESCENT; ADULT; CONTRACEPTIVES, ORAL, COMBINED; EMBRYO IMPLANTATION; ENDOMETRIUM; FEMALE; GENE EXPRESSION; HUMANS; MENSTRUAL CYCLE; OVULATION INDUCTION; YOUNG ADULT;

EID: 84900802846     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu065     Document Type: Article

References (36)

1. Al-Inany HG, Youssef MA, Aboulghar M, Broekmans F, Sterrenburg M, Smit J, Abou-Setta AM. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev 2011; 5:CD001750.
2. Anderson RE, Stein A, Paulson RJ, Stanczyk FZ, Vijod AG, Lobo RA. Effects of norethindrone on gonadotropin and ovarian steroid secretion when used for cycle programming during in vitro fertilization. Fertil Steril 1990; 54:96-101.
3. Barmat L, Chantilis S, Hurst B, Dickey R. A randomized prospective trial comparing gonadotropin releasing hormone (GnRH) antagonist/ recombinant follicle-stimulating hormone (rFSH) versus GnRH agonist/ rFSH in women pretreated with oral contraceptives before in vitro fertilization. Fertil Steril 2005;83:321-330.
4. Bellver J, Albert C, Labarta E, Pellicer A. Early pregnancy loss in women stimulated with gonadotropin releasing hormone antagonist protocols according to oral contraceptive pill pretreatment. Fertil Steril 2007; 87:1098-1101.
5. Benjamini Y, Yekutieli D. The control of the false discovery rate in multiple testing under dependency. Ann Stat 2001;4:1165-1188.
6. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001; 125:279-284.
7. Biljan M, Mahutte N, Dean N, Hemmings R, Bissonnette F, Tan SL. Effects of pre-Treatment with oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates. Fertil Steril 1998; 70:1063-1169.
8. Cédrin-Durnerin I, Bständig B, Parneix I, Bied-Damon V, Avril C, Decanter C, Hugues JN. Effects of oral contraceptive, synthetic progestogen or natural estrogen pre-Treatments on the hormonal profile and the antral follicle cohort before GnRH antagonist protocol. Hum Reprod 2007;22:109-116.
9. Cédrin-Durnerin I, Guivarc'h-Levêque A, Hugues JN. Pretreatment with estrogen does not affect IVF-ICSI cycle outcome compared with no pretreatment in GnRH antagonist protocol: A prospective randomized trial. Fertil Steril 2012;97:1359-1364.
10. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003;4:P3.
11. Devroey P, Aboulghar M, Garcia-Velasco JA, Griesinger G, Humaidan P, Kolibianakis E, Ledger W, Tomás C, Fauser BC. Improving the patient's experience of IVF/ICSI: A proposal for an ovarian stimulation protocol with GnRH antagonist co-Treatment. Hum Reprod 2009; 24:764-774.
12. Diáz-Gimeno P, Horcajadas JA, Martínez-Conejero JA, Esteban FJ, Alamá P, Pellicer A, Simón C. A genomic diagnostic tool for human endometrial receptivity based on the transcriptomic signature. Fertil Steril 2011; 95:50-60.
13. Diáz-Gimeno P, Ruiz-Alonso M, Blesa D, Bosch N, Martínez-Conejero JA, Alamá P, Garrido N, Pellicer A, Simón C. The accuracy and reproducibility of the endometrial receptivity array is superior to histological dating as diagnostic method for the endometrial factor. Fertil Steril 2013;99:508-517.
14. Fatemi HM, Doody K, Griesinger G, Witjes H, Mannaerts B. High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-Antagonist protocol. Hum Reprod 2013;28:442-452.
15. Fukuda M, Fukuda K, Andersen CY, Byskov AG. Doesanovulation induced by oral contraceptives favor pregnancy during the following two menstrual cycles? Fertil Steril 2000;73:742-747.
16. Garciá-Velasco JA, Bermejo A, Ruiz F, Martínez-Salazar J, Requena A, Pellicer A. Cycle scheduling with oral contraceptive pills in the GnRH antagonist protocol vs the long protocol: A randomized, controlled trial. Fertil Steril 2011;96:590-593.
17. Garrido-Gómez T, Ruiz-Alonso M, Blesa D, Diaz-Gimeno P, Vilella F, Simón C. Profiling the gene signature of endometrial receptivity: Clinical results. Fertil Steril 2013;99:1078-1185.
18. Griesinger G, Kolibianakis EM, Venetis C, Diedrich K, Tarlatzis B. Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: An updated meta-Analysis. Fertil Steril 2010;94:2382-2384.
19. Horcajadas JA, Goyri E, Higón MA, Martínez-Conejero JA, Gambadauro P, Garciá G, Meseguer M, Simón C, Pellicer A. Endometrial receptivity and implantation are not affected by the presence of uterine intramural leiomyomas: A clinical and functional genomics analysis. J Clin Endocrinol Metab 2008a;93:3490-3498.
20. Horcajadas JA, Mínguez P, Dopazo J, Esteban FJ, Domínguez F, Giudice LC, Pellicer A, Simón C. Controlled ovarian stimulation induces a functional genomic delay of the endometrium with potential clinical implications. J Clin Endocrinol Metab 2008b;93:4500-4510.
21. Kolibianakis EM, Papanikolau EG, Camus M, Tournaye H, Van Steirteghem AC, Devroey P. Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial. Hum Reprod 2006;21:352-357.
22. Labarta E, Martínez-Conejero JA, Alamá P, Horcajadas JA, Pellicer A, Simón C, Bosch E. Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: A functional genomics analysis. Hum Reprod 2011;26:1813-1825.
23. Liu Y, Zhang Y, Fu J, TanW. Inflammation-related gene expression profiles of endocervical polyps. J Interferon Cytokine Res 2012;32:191-197.
24. Medina I, Carbonell J, Pulido L, Madeira SC, Goetz S, Conesa A, Tárraga J, Pascual-Montano A, Nogales-Cadenas R, Santovo J. Babelomics: An integrative platform for the analysis of transcriptomics, proteomics and genomic data with advanced functional profiling. Nucleic Acids Res 2010; 38:W210-W213.
25. Meldrum D, Scott R, Levy M, Alper M, Noyes N. Oral contraceptive pretreatment in women undergoing controlled ovarian stimulation in ganirelix acetate cycles may, for a subset of patients, be associated with low serum luteinizing hormone levels, reduced ovarian response to gonadotropins, and early pregnancy loss. Fertil Steril 2009;91: 1963-1965.
26. Montaner D, Dopazo J. Multidimensional gene set analysis of genomic data. PLoS One 2010;5:e10348.
27. Pinkas H, Sapir O, Avrech O, Ben-Haroush A, Ashkenazi J, Fish B, Farhi J. The effect of oral contraceptive pill for cycle scheduling prior to GnRH antagonist protocol on IVF cycle parameters and pregnancy outcome. J Assist Reprod Genet 2008;25:29-33.
28. Rombauts L, Healy D, Norman RJ. Comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-Treated patients. Hum Reprod 2006;13:235-245.
29. Ruiz-Alonso M, Blesa D, Simón C. The genomics of the human endometrium. Biochim Biophys Acta 2012;1822:1931-1942.
30. Sartor MA, Mahavisno V, Keshamouni VG, Cavalcoli J, Wright Z, Karnovsky A, Kuick R, Jagadish HV, Mirel B, Weymouth T. ConceptGen: A gene set enrichment and gene set relation mapping tool. Bioinformatics 2010;26:456-463.
31. Smulders B, Van Oirschot S, Farquhar C, Rombauts L, Kremer J. Oral contraceptive pill, progestogen or estrogen pre-Treatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques. Cochrane Database Syst Rev 2010; CD006109.
32. Talbi S, Hamilton AE, Vo KC, Tulac S, Overgaard MT, Dosiou C, Le Shay N, Nezhat CN, Kempson R, Lessey BA. et al. Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women. Endocrinology 2006; 147:1097-1121.
33. TremellenKP, Lane M.Avoidance ofweekend oocyte retrievals duringGnRH antagonist treatment by simple advancement or delay of hCG administration does not adversely affect IVF live birth outcomes. Hum Reprod 2010;25:1219-1224.
34. Tsai CC, Yen SC. The effect of ethinyl-estradiol administration during early follicular phase on the gonadotrophin levels and ovarian function. J Clin Endocrinol Metab 1971;33:917-923.
35. Van Heusden AM, Coelingh Bennink HJ, Fauser BC. FSH and ovarian response: Spontaneous recovery of pituitary-ovarian activity during the pill-free period vs exogenous recombinant FSH during high-dose combined oral contraceptives. Clin Endocrinol (Oxf) 2002;56:509-517.
36. Zorn JR, Boyer P, Guichard A. Neveron Sunday: Programming for IVF-ET and GIFT. Lancet 1987;1:385-386.